A clinical trial to compare the efficacy of 7-day and 14-day triple drug therapy for the eradication treatment of Helicobacter pylori infectio
Phase 4
- Conditions
- Health Condition 1: null- Patients with symptomatic Helicobacter pylori infection
- Registration Number
- CTRI/2011/11/002139
- Lead Sponsor
- Pradeep Kumar P
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 320
Inclusion Criteria
Patients with symptomatic H.pylori infection as evidenced by standard diagnostic methods.
Exclusion Criteria
1) Age 18 years
2) Use of proton pump inhibitors in the last 1
week
3) Use of antibiotics in the last 4 weeks
4) Patients with allergy to any of the drugs
used in the trial
5) Pregnant and breast feeding women
6) Patients with advanced chronic hepatic or
renal disease
7) Previous history of H.pylori eradication
therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of H.pylori eradication assessed by stool antigen assayTimepoint: Efficacy of H.pylori eradication assessed by stool antigen assay
- Secondary Outcome Measures
Name Time Method Various endoscopic findings in patients with symptomatic H.pylori infection <br/ ><br>Factors influencing successful eradication treatment <br/ ><br>Symptomatic improvement following eradication therapyTimepoint: six months